Clinical Validation of the InterVenn Ovarian Cancer Liquid Biopsy: VOCAL Study
To evaluate the clinical performance for the InterVenn Ovarian Cancer Liquid Biopsy by collecting and storing blood samples and characterizing protein biomarkers in the blood of cancer vs. non-cancer patients.
DiagnosisPelvic mass and that may or may not have surgery.
Newly diagnosed pelvic mass confirmed by imaging
Patients must sign an approved informed consent and authorization permitting release of personal health information.
- Health questionnaire
- Blood sample for analysis
For more information, visit ClinicalTrials.gov